MCNEILL JONATHAN enters CRESCENT BIOPHARMA, INC. with 134.20K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 6/23/2025ACC: 0001104659-25-061796
Officer· See Remarks
Since Jun 2025
134.20K
Baseline shares
100% direct
134.20K
Direct ownership
1 position
402.60K
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Ordinary Shares
DirectShares owned134.20K
Total
134.20K direct134.20K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 134.20K | Direct |
| Total | 134.20K | 134.20K direct |
Derivative Holdings1
Stock Option (Right to Buy)
DirectUnderlying security
Ordinary Shares
Underlying shares
402.60K
Shares owned
N/A
Exercise price
6.16
Expiration
—
Exercise window
—
Total
Underlying
402.60K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Ordinary Shares | 6.16 | — | — | 402.60K | N/A |
| Total | 402.60K | 0.00 | ||||